RxDoctor Payments Data

Christopher Martin, MD

Orthopaedic Surgery · Salt Lake City, UTNPI 1891787339

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,151,580 of the $1,152,079 with a category attached, or 100.0%. Zimmer Biomet accounts for 95.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $410,370 and has fallen 98.2% since, to $7,378 in 2025. Among orthopaedic surgery clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,152,079in general payments, 2019–2025

Across 47 payments — averaging $24,512 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$1.1M
  • Arthrex$52K
  • Alphatec Spine, Inc$324
  • Johnson & Johnson$65
  • Boston Scientific$52
  • Medtronic$35
  • plus $22 from 1 others

What the payments were for

  • Royalty or licence$1,151,580100%
  • Food & beverage$4990%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,152,079 in reported general payments places this provider in the 95th percentile of 221 orthopaedic surgery providers in Utah.

See all orthopaedic surgery providers in Utah

Medicare billing

Part B allowed, 2024
$38,119
Medicare patients
105
Services billed
188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →